uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

QURE uniQure NV

Pre-Mkt 08-11 08:26:46 EDT

46.06

-0.36

-0.78%

盘前46.00

-0.06-0.13%

08:01 EDT

High47.00	Low45.12	Vol1.10M
Open46.06	D1 Closing46.42	Amplitude4.04%
Mkt Cap3.20B	Tradable Cap2.83B	Total Shares69.37M
T/O50.77M	T/O Rate1.79%	Tradable Shares61.40M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"QURE","market":"US","secType":"STK","nameCN":"uniQure NV","latestPrice":46.06,"timestamp":1786392000000,"preClose":46.42,"halted":0,"volume":1096878,"hourTrading":{"tag":"盘前","latestPrice":46,"preClose":46.06,"latestTime":"08:01 EDT","volume":208,"amount":9585.36384,"timestamp":1786449679338,"change":-0.06,"changeRate":-0.001303,"amplitude":0.084759},"delay":0,"changeRate":-0.00775527789745798,"floatShares":61398800,"shares":69366400,"eps":-4.039896,"marketStatus":"Pre-Mkt","change":-0.36,"latestTime":"08-11 08:26:46 EDT","open":46.06,"high":47,"low":45.1237,"amount":50768671.360356,"amplitude":0.04042,"askPrice":46.5,"askSize":20,"bidPrice":45.78,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-4.039896,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786455000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1391576400000,"exchange":"NASDAQ","adjPreClose":46.06,"preHourTrading":{"tag":"盘前","latestPrice":46,"preClose":46.06,"latestTime":"08:01 EDT","volume":208,"amount":9585.36384,"timestamp":1786449679338,"change":-0.06,"changeRate":-0.001303,"amplitude":0.084759},"postHourTrading":{"tag":"盘后","latestPrice":46.11,"preClose":46.06,"latestTime":"19:41 EDT","volume":13424,"amount":619702.75,"timestamp":1786405263793,"change":0.05,"changeRate":0.001086,"amplitude":0.010638},"volumeRatio":0.8791201042264157,"optionData":{"bulkOrders":[{"symbol":"QURE","call":true,"expireDate":1799989200000,"strike":"70.0","timestamp":1786391678900,"price":5.6,"volume":3750,"amount":2100000,"type":"-"},{"symbol":"QURE","call":true,"expireDate":1799989200000,"strike":"70.0","timestamp":1786391678900,"price":5.7,"volume":3750,"amount":2137500,"type":"-"}]},"impliedVol":1.0177,"impliedVolPercentile":0.348},"requestUrl":"/m/hq/s/QURE/tweets","defaultTab":"tweets","newsList":[{"id":"2655735583","title":"uniQure (QURE) Stock Rises On Cash Runway Despite Deepening Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2655735583","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655735583?lang=en_us&edition=fundamental","pubTime":"2026-07-31 15:11","pubTimestamp":1785481911,"startTime":"0","endTime":"0","summary":"uniQure stock jumped 5.3% to US$42.19 after its Q2 release, a sharp move for a gene therapy developer that is still posting deep losses. The headlines are not about earnings beats. The story is about whether the cash and pipeline can carry the company across a long and expensive bridge to potential commercial launches.\n\nThe quarter showed another heavy quarterly loss with basic earnings per share of US$1.22 in the red and revenue of just US$5.8m. The key focus now is the balance sheet...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/uniqure-qure-stock-rises-on-cash-runway-despite-deepening-lo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/uniqure-qure-stock-rises-on-cash-runway-despite-deepening-lo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HELS","QURE","LU0889565916.HKD","BK4139","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655870856","title":"Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and uniQure (QURE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655870856","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655870856?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:40","pubTimestamp":1785415211,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and u...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-teladoc-tdoc-fortrea-holdings-inc-ftre-and-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-teladoc-tdoc-fortrea-holdings-inc-ftre-and-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0109394709.USD","BK4167","BK4121","BK4534","LU0128526141.USD","XBI","LU0320765992.SGD","BK4581","FTRE","LU1861559042.SGD","BK4588","BK4567","LU0029874061.USD","HCSG","BK4139","LU1861558580.USD","XLV","BK4504","LABU","BK4585","LU0889565916.HKD","BK4548","TDOC","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655877598","title":"uniQure Raised to Outperform from Peer Perform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2655877598","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655877598?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:27","pubTimestamp":1785414420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QURE/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE","LU0320765992.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655873973","title":"Uniqure Nv : Barclays Cuts Target Price to $60 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2655873973","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655873973?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:32","pubTimestamp":1785407563,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W1N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","QURE","BK4139","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655897353","title":"Uniqure NV Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2655897353","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655897353?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:48","pubTimestamp":1785343722,"startTime":"0","endTime":"0","summary":"Uniqure NV reports results for the quarter ended June 30 - Earnings SummaryUniqure NVQURE.OQreported a quarterly adjusted loss of $1.22 per share for the quarter ended June 30, lower than the same qua","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL8N43V2OA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4139","QURE","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655893767","title":"UniQure Q2 Net Loss Widens, Revenue Increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2655893767","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655893767?lang=en_us&edition=fundamental","pubTime":"2026-07-29 21:05","pubTimestamp":1785330327,"startTime":"0","endTime":"0","summary":"UniQure  reported a Q2 net loss Wednesday of $1.22 per diluted share, widening from a loss of $0.69 a year earlier.Analysts surveyed by FactSet expected a loss of $0.82.Revenue for the quarter ended June 30 was $5.8 million, up from $5.3 million a year earlier.Analysts polled by FactSet expected $5.4 million.Shares of the company were up nearly 6% in recent Wednesday premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655586274","title":"Earnings Flash (QURE) uniQure Posts Q2 Loss of $1.22 a Share, vs. FactSet Est of $0.82 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2655586274","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655586274?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:34","pubTimestamp":1785324897,"startTime":"0","endTime":"0","summary":"Earnings Flash (QURE) uniQure Posts Q2 Loss of $1.22 a Share, vs. FactSet Est of $0.82 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655862217","title":"U.S.-Listed Shares of Uniqure up 3.6% Premarket After Q2 Revenue Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2655862217","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655862217?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:33","pubTimestamp":1785324806,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL4N43V163:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","LU0889565916.HKD","BK4139","LU0320765992.SGD","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655659862","title":"Netherlands' uniQure Q2 Revenue Rises, Beats Analyst Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2655659862","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655659862?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:24","pubTimestamp":1785324292,"startTime":"0","endTime":"0","summary":"Netherlands' uniQure Q2 revenue rises, beats analyst expectationsOverviewNetherlands gene therapy firm's Q2 revenue rose and beat analyst expectationsNet loss widened in Q2 due to higher SG&A and non-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL1N43V0I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","QURE","BK4139","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655181864","title":"uniQure Q2 EPS $(1.22) Misses $(0.82) Estimate, Sales $5.800M Beat $5.467M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655181864","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655181864?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:07","pubTimestamp":1785323224,"startTime":"0","endTime":"0","summary":"uniQure (NASDAQ:QURE) reported quarterly losses of $(1.22) per share which missed the analyst consensus estimate of $(0.82) by 48.78 percent. This is a 76.81 percent decrease over losses of $(0.69) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60754535/uniqure-q2-eps-1-22-misses-0-82-estimate-sales-5-800m-beat-5-467m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4139","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655862328","title":"uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2655862328","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655862328?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:05","pubTimestamp":1785323100,"startTime":"0","endTime":"0","summary":"~ U.S. and U.K. regulatory submissions for AMT-130 for Huntington’s disease on track as planned for the third quarter of 2026 ~ ~ Topline four-year data from the Phase I/II study of AMT-130 expected i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/29/3335112/0/en/uniQure-Announces-Second-Quarter-2026-Financial-Results-and-Provides-Company-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","LU0320765992.SGD","LU0109394709.USD","BK4585","QURE","BK4139","HELS","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653540027","title":"uniQure to Announce Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2653540027","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653540027?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:05","pubTimestamp":1784718300,"startTime":"0","endTime":"0","summary":"~ uniQure to host earnings call on Wednesday, July 29, 2026 at 8:30 a.m. ET ~LEXINGTON, Mass. and AMSTERDAM, July  22, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy comp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/22/3331240/0/en/uniQure-to-Announce-Second-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","QURE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653899437","title":"uniQure (QURE) Gets a Hold from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2653899437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653899437?lang=en_us&edition=fundamental","pubTime":"2026-07-22 06:19","pubTimestamp":1784672388,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Salveen Richter from Goldman Sachs maintained a Hold rating on uniQure, with a price target of $46.00. The company’...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/uniqure-qure-gets-a-hold-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/uniqure-qure-gets-a-hold-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0004086264.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","IE00BFXG1179.USD","LU0109394709.USD","LU2471134523.USD","BK4127","IE00B19Z3581.USD","LU0048573561.USD","LU0251131958.USD","LU2237443549.SGD","LU2471134796.USD","LU0942090050.USD","LU2471134952.CNY","GSX","LU1868837136.USD","LU1868836591.USD","BK4504","LU2237443382.USD","LU2237443622.USD","LU2750360997.AUD","LU1894683348.USD","QURE","IE0004091025.USD","IE0002270589.USD","LU0251142724.SGD","LU0345770993.USD","LU0106831901.USD","LU1668664300.SGD","LU0061475181.USD","BK4550","LU1868836914.USD","LU0096364046.USD","LU1868836757.USD","LU0868494708.USD","LU1894683264.USD","LU2237443978.SGD","BK4585","LU1791807156.HKD","LU2265009873.SGD","LU0742534661.SGD","BK4533","BK4588","LU2471134879.HKD","LU2750360641.GBP","BK4139","LU1868837300.USD","LU1804176565.USD","LU2237438978.USD","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651126602","title":"uniQure (QURE) Rebound Puts AMT 130 Valuation Debate Back In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2651126602","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651126602?lang=en_us&edition=fundamental","pubTime":"2026-07-14 09:26","pubTimestamp":1783992360,"startTime":"0","endTime":"0","summary":"uniQure (QURE) has drawn fresh attention after a strong rebound in its share price over the past month and past 3 months, prompting investors to reassess the gene therapy company’s risk and return trade off.\nSee our latest analysis for uniQure.\nOver the past year, uniQure’s 182.47% total shareholder return and 285.92% three year total shareholder return contrast with a recent 3.59% one day share price decline. This suggests strong longer term momentum alongside short term volatility as...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/uniqure-qure-rebound-puts-amt-130-valuation-debate-back-in-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/uniqure-qure-rebound-puts-amt-130-valuation-debate-back-in-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DTCR","PSR","BK4084","BK4139","DFGR","URE","BYRE","BK4581","QURE","XLRE","IDGT","CRED","VNQ","LU0889565916.HKD","SRVR","BK4588","LU0320765992.SGD","LU0109394709.USD","AMT","BK4585","FREL","BK4554","WTRE","REAI","BK4219","DTRE","ICF","AVRE","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649930462","title":"Uniqure CEO Matthew Kapusta Disposes of USD 956,528 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930462","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930462?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:48","pubTimestamp":1783457296,"startTime":"0","endTime":"0","summary":"uniQure CEO Matthew Kapusta disposes of USD 956,528 in common sharesuniQure CEO and Managing Director Matthew C. Kapusta exercised stock options for 21,082 ordinary shares at $19.39 on July 2, 2026.He","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL1Z1KyF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Uniqure CEO Matthew Kapusta Disposes of USD 956,528 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4139","LU0889565916.HKD","LU0109394709.USD","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648633055","title":"Uniqure Director Jack Kaye Disposes of Ordinary Shares Worth $954,615.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2648633055","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648633055?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:56","pubTimestamp":1783025760,"startTime":"0","endTime":"0","summary":"uniQure director Jack Kaye disposes of ordinary shares worth $954,615.3uniQure director Jack Kaye cut his ordinary-share stake to 25,996 shares in transactions dated June 30, 2026.Sold 21,167 ordinary","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL7Vj9xM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Uniqure Director Jack Kaye Disposes of Ordinary Shares Worth $954,615.3","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE","LU0320765992.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124287037","title":"Movement Alert｜uniQure Falls 8.11% in Regular Trading, Dilution Pressure From Upsized $259 Million Offering Continues to Weigh on Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1124287037","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124287037?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:26","pubTimestamp":1783009581,"startTime":"0","endTime":"0","summary":"On July 3, uniQure N.V. declined 8.11% in regular trading, trading at $41.4/share with turnover of approximately $60.42 million. The stock has now fallen well below the $45.50 offering price from its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647761378","title":"Uniqure is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2647761378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647761378?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:17","pubTimestamp":1782728220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QURE/analyst-ratings(END) Dow Jones NewswiresJune 29, 2026 06:17 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378517","title":"uniQure price target raised to $80 from $50 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378517?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:00","pubTimestamp":1782727216,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on uniQure (QURE) to $80 from $50 and keeps a Buy rating on the shares. The firm believes the June 1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/uniqure-price-target-raised-to-80-from-50-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/uniqure-price-target-raised-to-80-from-50-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","QURE","BK4139","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646788398","title":"Uniqure CEO Matthew Kapusta Sells 35,412 Shares for $1.77 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2646788398","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646788398?lang=en_us&edition=fundamental","pubTime":"2026-06-27 05:16","pubTimestamp":1782508567,"startTime":"0","endTime":"0","summary":"uniQure CEO Matthew Kapusta sells 35,412 shares for $1.77 millionuniQure CEO and Managing Director Matthew C. Kapusta cut his ordinary share stake to 519,227 shares in transactions on June 24-25.Dispo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL3wNck4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Uniqure CEO Matthew Kapusta Sells 35,412 Shares for $1.77 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4139","QURE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.uniqure.com","stockEarnings":[{"period":"1week","weight":0.0454},{"period":"1month","weight":0.0805},{"period":"3month","weight":0.5828},{"period":"6month","weight":0.9104},{"period":"1year","weight":2.4684},{"period":"ytd","weight":0.9248}],"compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.0239},{"period":"3month","weight":0.0472},{"period":"6month","weight":0.1172},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1336}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.009035},{"month":2,"riseRate":0.5,"avgChangeRate":0.032875},{"month":3,"riseRate":0.307692,"avgChangeRate":-0.046417},{"month":4,"riseRate":0.461538,"avgChangeRate":0.033828},{"month":5,"riseRate":0.692308,"avgChangeRate":0.072742},{"month":6,"riseRate":0.461538,"avgChangeRate":0.038554},{"month":7,"riseRate":0.230769,"avgChangeRate":0.026458},{"month":8,"riseRate":0.538462,"avgChangeRate":0.009808},{"month":9,"riseRate":0.25,"avgChangeRate":0.122705},{"month":10,"riseRate":0.5,"avgChangeRate":0.060394},{"month":11,"riseRate":0.75,"avgChangeRate":0.0616},{"month":12,"riseRate":0.25,"avgChangeRate":0.125134}],"exchange":"NASDAQ","name":"uniQure NV","nameEN":"uniQure NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest uniQure NV(QURE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"uniQure NV,QURE,uniQure NV股票,uniQure NV股票老虎,uniQure NV股票老虎国际,uniQure NV行情,uniQure NV股票行情,uniQure NV股价,uniQure NV股市,uniQure NV股票价格,uniQure NV股票交易,uniQure NV股票购买,uniQure NV股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest uniQure NV(QURE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}